Ensuring medication remains effective from the moment it leaves our facility until it reaches the patient is one of the greatest challenges in pharmaceutical manufacturing. In regions like the Horn of Africa, where temperatures can exceed 45°C and humidity levels soar above 90%, stability testing becomes not just a regulatory requirement but a critical public health imperative.
ICH Guidelines and Accelerated Stability Studies
Tonga Pharmaceuticals adheres strictly to the International Council for Harmonisation (ICH) Q1 guidelines for stability testing. Our protocols include accelerated stability studies conducted at 40°C ± 2°C and 75% ± 5% relative humidity for six months. These harsh conditions simulate years of real-world exposure, allowing us to predict shelf life with remarkable accuracy. Each batch undergoes rigorous physicochemical, microbiological, and biological testing at predefined intervals, ensuring compliance with both ICH standards and Ethiopian Food and Drug Authority (EFDA) requirements.
Our state-of-the-art stability chambers replicate the diverse microclimates found across Ethiopia's varied topography — from the scorching lowlands of Afar to the humid highlands of Addis Ababa. This comprehensive approach means our formulations are validated against the actual environmental conditions our patients experience daily.
Real-Time Monitoring in Ethiopian Storage Facilities
Beyond controlled laboratory settings, Tonga Pharma maintains a network of IoT-enabled sensors across our regional distribution centers and partner pharmacy storage facilities. These sensors continuously log temperature and humidity data, transmitting real-time information to our central quality assurance hub. This live monitoring system has proven invaluable in identifying potential storage anomalies before they compromise product integrity.
Over the past three years, our monitoring network has recorded over 2.4 million data points, revealing that 94.7% of storage conditions remain within acceptable parameters. The remaining 5.3% triggered automated alerts that enabled swift corrective action — a testament to the effectiveness of our proactive quality management system.
Ensuring Efficacy Across Climate Zones
Our stability programs go beyond standard shelf-life determinations. We conduct zone-specific stability assessments for products destined for different climate regions within Ethiopia. Formulations intended for distribution in the Somali Regional State undergo additional stress testing that accounts for prolonged exposure to extreme arid conditions, while products for the Southern Nations receive enhanced moisture resistance evaluations.
Through this meticulous, science-driven approach to stability testing, Tonga Pharmaceuticals guarantees that every tablet, capsule, and syrup we produce maintains its full therapeutic potency — regardless of where in the Horn of Africa it is needed. Our commitment to pharmaceutical excellence means patients and healthcare providers can trust that our medications deliver consistent, reliable outcomes, even under the most demanding environmental conditions.